title: Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barre syndrome.
abstract: Intravenous immunoglobulin (IVIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndrome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome.
authors: Karadeniz Technical University, Medical Faculty, Neurology Department, Trabzon, Turkey.
authors: S K
authors: SK
authors: Velioğlu
authors: M
authors: M
authors: Ozmenoğlu
authors: C
authors: C
authors: Boz